ClinicalTrialsFinder

Second Primary Squamous Cell Carcinoma of the Head and Neck Clinical Trials in Boston, Massachusetts

1 recruitingBoston, Massachusetts

Showing 1–1 of 1 trials

Recruiting
Phase 2

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Head and Neck CancerHead and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma+2 more
Dana-Farber Cancer Institute28 enrolled2 locationsNCT05726370